11. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Issue 6 (17th March 2017) Authors: Adams, Leon A; Anstee, Quentin M; Tilg, Herbert; Targher, Giovanni Journal: Gut Issue: Volume 66:Issue 6(2017) Page Start: 1138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls. Issue 1 (30th June 2014) Authors: Hallsworth, Kate; Thoma, Christian; Moore, Sarah; Ploetz, Thomas; Anstee, Quentin M; Taylor, Roy; Day, Christopher P; Trenell, Michael I Journal: Frontline gastroenterology Issue: Volume 6:Issue 1(2015) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Issue 3 (24th December 2013) Authors: Dyson, Jessica K; Anstee, Quentin M; McPherson, Stuart Journal: Frontline gastroenterology Issue: Volume 5:Issue 3(2014) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Nutrigenetics-based intervention approach for adults with non-alcoholic fatty liver disease (NAFLD): study protocol for a randomised controlled feasibility trial. Issue 4 (8th April 2021) Authors: Haigh, Laura; McPherson, Stuart; Mathers, John C; Anstee, Quentin M Journal: BMJ open Issue: Volume 11:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019) Authors: Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019) Authors: Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019) Authors: Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. OTU-14 Positive results from REGENERATE: a phase 3 international, randomized, placebo-controlled study evaluating obeticholic acid treatment for NASH. (June 2019) Authors: Younossi, Zobair; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Zaru, Luna; MacConell, Leigh; Shringarpure, Reshma; Harrison, Stephen; Sanyal, Arun Journal: Gut Issue: Volume 68(2019)Supplement 2 Page Start: A108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience. Issue 4 (23rd May 2013) Authors: Cobbold, Jeremy F L; Raveendran, Sarrah; Peake, Christopher M; Anstee, Quentin M; Yee, Michael S; Thursz, Mark R Journal: Frontline gastroenterology Issue: Volume 4:Issue 4(2013) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease. Issue 7 (21st March 2016) Authors: Hardy, Timothy; Zeybel, Mujdat; Day, Christopher P; Dipper, Christian; Masson, Steven; McPherson, Stuart; Henderson, Elsbeth; Tiniakos, Dina; White, Steve; French, Jeremy; Mann, Derek A; Anstee, Quentin M; Mann, Jelena Journal: Gut Issue: Volume 66:Issue 7(2017) Page Start: 1321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗